Finance

Beta
Lists
542650:BOM
Metropolis Healthcare Ltd
₹533.40
-1.87%
(-10.15) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 542650...
Open
₹543.60
High
₹553.00
Low
₹530.65
Mkt. cap
110.02B
Avg. vol.
57.22K
Volume
4.68K
Dividend
0.56%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
58.04
52-wk high
₹599.90
52-wk low
₹411.05
EPS
₹9.19
No. of employees
5K
Open
₹543.60
High
₹553.00
Low
₹530.65
Mkt. cap
110.02B
Avg. vol.
57.22K
Volume
4.68K
Dividend
0.56%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
58.04
52-wk high
₹599.90
52-wk low
₹411.05
EPS
₹9.19
No. of employees
5K
News stories
From sources across the web
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOVijender Singh
Employees4.82K
Founded1980
Headquarters-
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.86B
4.29B
4.06B
4.25B
Cost of goods sold
790.49M
877.48M
792.37M
784.82M
Cost of revenue
790.49M
877.48M
792.37M
784.82M
Research and development expenses
56.74M
49.67M
80.57M
43.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
922.79M
953.93M
942.25M
954.67M
Operating expense
2.48B
2.66B
2.64B
2.77B
Total operating expenses
3.27B
3.53B
3.43B
3.55B
Operating income
589.12M
758.17M
629.68M
694.27M
Other non operating income
75.16M
8.91M
90.16M
81.62M
EBT including unusual items
612.30M
710.26M
571.57M
697.63M
EBT excluding unusual items
612.30M
710.26M
662.53M
696.56M
Income tax expense
159.85M
181.36M
150.70M
188.03M
Effective tax rate
26.11%
25.53%
26.37%
26.95%
Other operating expenses
1.19B
1.33B
1.30B
1.38B
Net income
450.61M
526.68M
413.86M
509.03M
Net profit margin
11.67%
12.27%
10.20%
11.99%
Earnings per share
2.16
2.53
2.31
2.46
Interest and investment income
-
-
-
-
Interest expense
-51.98M
-56.82M
-57.30M
-79.33M
Net interest expenses
-51.98M
-56.82M
-57.30M
-79.33M
Depreciation and amortization charges
308.45M
324.08M
318.78M
385.90M
EBITDA
640.18M
1.07B
680.74M
1.03B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more